Search Results 271-280 of 16358 for infliximab

  1. Ofatumumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Ofatumumab injection is also used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and ...

  2. Inotuzumab ozogamicin (intravenous route) - Side effects & uses - Mayo Clinic

    Inotuzumab ozogamicin injection is used to treat acute lymphoblastic leukemia (ALL) that has come back or after other medicines did not work well. Leukemia is a ...

  3. Abatacept in Immune Checkpoint Inhibitor Myocarditis (ATRIUM) - Mayo Clinic

    ... infliximab, and plasma exchange. Currently enrolled in another interventional study utilizing systemic agents for the management of ICI-related toxicities ...

  4. Rifaximin (oral route) - Side effects & dosage - Mayo Clinic

    Rifaximin is used to treat traveler's diarrhea that is caused by a bacteria called Escherichia coli. It is also used to prevent hepatic encephalopathy, which is ...

  5. Ibrexafungerp (oral route) - Side effects & dosage - Mayo Clinic

    Description. Ibrexafungerp is used to treat fungal or yeast infections, including vulvovaginal candidiasis. It is also used to reduce the risk of the ...

  6. Short Bowel Syndrome and Teduglutide VS Placebo - Mayo Clinic

    Use of Infliximab, growth hormone or growth factors such as native GLP-2 or other biological therapy within the last 12 weeks. Use of Methotrexate ...

  7. Cancer Clinical Trials - Medical Professionals

    This study is researching an experimental drug called ubamatamab, also referred to as "study drug". The study is focused on patients who have advanced ...

  8. A Rollover Extension Program (Rep) to Evaluate the Long-Term Safety AndTolerability of Open Label Iptacopan in Adult Participants With Primary Iga Nephropathy - Mayo Clinic

    Participants treated with immunosuppressive or other immunmodulatory agents such as but not limited to cyclophosphamide, rituximab, infliximab, eculizumab ...

  9. Hodgkin Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...

  10. A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma - Mayo Clinic

    Has received immunosuppressive medications including but not limited to CellCept, methotrexate, infliximab, anakinra, tocilizumab, cyclosporine, or ...